StemCells, Inc. Announces Completion of the First of Two Cohorts in its Dry Age-Related Macular Degeneration Trial

[GlobeNewswire] – NEWARK, Calif. — StemCells, Inc. announced today that it has completed enrollment of the first of two planned patient cohorts in the Company’s clinical trial of its proprietary HuCNS-SC(R) product candidate … more

View todays social media effects on STEM

View the latest stocks trending across Twitter. Click to view dashboard

See who StemCells is hiring next, click here to view